BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16900213)

  • 1. Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior.
    Rahmatpanah FB; Carstens S; Guo J; Sjahputera O; Taylor KH; Duff D; Shi H; Davis JW; Hooshmand SI; Chitma-Matsiga R; Caldwell CW
    Leukemia; 2006 Oct; 20(10):1855-62. PubMed ID: 16900213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential DNA methylation of gene promoters in small B-cell lymphomas.
    Guo J; Burger M; Nimmrich I; Maier S; Becker E; Genc B; Duff D; Rahmatpanah F; Chitma-Matsiga R; Shi H; Berlin K; Huang TH; Caldwell CW
    Am J Clin Pathol; 2005 Sep; 124(3):430-9. PubMed ID: 16191512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis.
    Thieblemont C; Chettab K; Felman P; Callet-Bauchu E; Traverse-Glehen A; Berger F; Dumontet C; Cerutti C; Baseggio L; Salles G; Paultre C; Coiffier B; McGregor JL
    Leukemia; 2002 Nov; 16(11):2326-9. PubMed ID: 12399979
    [No Abstract]   [Full Text] [Related]  

  • 9. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma.
    Schmechel SC; LeVasseur RJ; Yang KH; Koehler KM; Kussick SJ; Sabath DE
    Leukemia; 2004 Apr; 18(4):841-55. PubMed ID: 14961037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.
    Nakagawa T; Pimkhaokham A; Suzuki E; Omura K; Inazawa J; Imoto I
    Cancer Sci; 2006 Oct; 97(10):1070-4. PubMed ID: 16918994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
    Mestre-Escorihuela C; Rubio-Moscardo F; Richter JA; Siebert R; Climent J; Fresquet V; Beltran E; Agirre X; Marugan I; Marín M; Rosenwald A; Sugimoto KJ; Wheat LM; Karran EL; García JF; Sanchez L; Prosper F; Staudt LM; Pinkel D; Dyer MJ; Martinez-Climent JA
    Blood; 2007 Jan; 109(1):271-80. PubMed ID: 16960149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gene expression signatures for molecular classification in human leukemia cells.
    Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
    Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
    Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
    Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
    Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
    Nakatsuka S; Takakuwa T; Aozasa K
    Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.
    Taylor KH; Kramer RS; Davis JW; Guo J; Duff DJ; Xu D; Caldwell CW; Shi H
    Cancer Res; 2007 Sep; 67(18):8511-8. PubMed ID: 17875690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.